HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
China
201580042841.1
Filed on 2015-06-12
201580042841.1
Filed on 2015-06-12
HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
Canada
2951924
Filed on 2015-06-12
2951924
Filed on 2015-06-12
HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
Australia
2015274333
Filed on 2015-06-12
2015274333
Filed on 2015-06-12
Cyclopentane-Peptide Nucleic Acids For Qualitative And Quantitative Detection Of Nucleic Acids
Ireland
13753962.3
Filed on 2015-02-11
13753962.3
Filed on 2015-02-11
Cyclopentane-Peptide Nucleic Acids For Qualitative And Quantitative Detection Of Nucleic Acids
United Kingdom
13753962.3
Filed on 2015-02-11
13753962.3
Filed on 2015-02-11
Cyclopentane-Peptide Nucleic Acids For Qualitative And Quantitative Detection Of Nucleic Acids
France
13753962.3
Filed on 2015-02-11
13753962.3
Filed on 2015-02-11
Cyclopentane-Peptide Nucleic Acids For Qualitative And Quantitative Detection Of Nucleic Acids
Germany
13753962.3
Filed on 2015-02-11
13753962.3
Filed on 2015-02-11
IGF2BP1 AND/OR IGF2BP3 FOR TREATMENT
Patent Cooperation Treaty
PCT/US16/060084
Filed on 2016-11-02
PCT/US16/060084
Filed on 2016-11-02
A3 Adenosine Receptor Antagonists and Partial Agonists
United Kingdom
09791060.8
Filed on 2011-01-28
09791060.8
Filed on 2011-01-28
A3 Adenosine Receptor Antagonists and Partial Agonists
France
09791060.8
Filed on 2011-01-28
09791060.8
Filed on 2011-01-28